...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: A Speculative Theory
Reply New Message
Prev Message Back To Forum Threaded View Next Message

"I could see an argument on their part that they think the very best thing to do would be to invest in Resverlogix.   And yes, I'm sure many people would not agree with that."

Only the RVX shareholders, because you need a bailout.  Give it up.  You're not going to influence management.

All moot.  Doesn't RVX need 68 million really really soon?  Neither ZC nor ZE has any cash to invest.

It would be a speculative gamble.  None too smart.

1 Recommendations
Reply New Message
Prev Message Back To Forum Threaded View Next Message
Share
Share
New Message
Please login to post a reply